OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Olivier Bénichou, Tamer Coşkun, Malgorzata D. Gonciarz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 274-286.e10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

What is the pipeline for future medications for obesity?
Eka Melson, Uzma Ashraf, Dimitris Papamargaritis, et al.
International Journal of Obesity (2024)
Open Access | Times Cited: 104

GDF15 linked to maternal risk of nausea and vomiting during pregnancy
Marlena S. Fejzo, Nuno Rocha, Irène Cimino, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 760-767
Open Access | Times Cited: 77

Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
Simon Kloock, Christian G. Ziegler, Ulrich Dischinger
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108549-108549
Open Access | Times Cited: 49

Obesity and the kidney: mechanistic links and therapeutic advances
Kevin Yau, Rachel Kuah, David Z.I. Cherney, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 6, pp. 321-335
Closed Access | Times Cited: 31

GDF15 increases insulin action in the liver and adipose tissue via a β-adrenergic receptor-mediated mechanism
Kim A. Sjøberg, Casper M. Sigvardsen, Abdiel Alvarado-Diaz, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1327-1340.e5
Closed Access | Times Cited: 38

Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases
Benyuan Zhang, Joon Young Chang, Min Hee Lee, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 1, pp. 1-18
Open Access | Times Cited: 8

GDF15 is a major determinant of ketogenic diet-induced weight loss
Jun Lu, Mengqing Zhu, Bo Xia, et al.
Cell Metabolism (2023) Vol. 35, Iss. 12, pp. 2165-2182.e7
Open Access | Times Cited: 20

The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response
Jayashree Jena, Luis Miguel García-Peña, Renata O. Pereira
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17

mTORC1 in energy expenditure: consequences for obesity
C. Allard, Cristina Miralpeix, Antonio J. López-Gambero, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 4, pp. 239-251
Closed Access | Times Cited: 6

Preventing obesity, insulin resistance and type 2 diabetes by targeting MT1-MMP
Pallavi Asthana, Hoi Leong Xavier Wong
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 4, pp. 167081-167081
Closed Access | Times Cited: 6

Identification and characterization of human GDF15 knockouts
Allan Gurtan, Shareef Khalid, Christopher Koch, et al.
Nature Metabolism (2024)
Closed Access | Times Cited: 6

Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Michael M. Richter, I Kemp, Sara Heebøll, et al.
Metabolism (2024) Vol. 156, pp. 155915-155915
Open Access | Times Cited: 5

Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH
Laurent L’homme, Benan Pelin Sermikli, Joel T. Haas, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Geroscience in heart failure: the search for therapeutic targets in the shared pathobiology of human aging and heart failure
Claire Castro, Constance Delwarde, Yanxi Shi, et al.
The Journal of Cardiovascular Aging (2025) Vol. 5, Iss. 1
Open Access

Future Perspectives in the Management of Obesity
Shilpa Chugh Garcha, Sanjay Kalra
(2025), pp. 121-154
Closed Access

GDF15 analogs as obesity therapeutics
Samuel N. Breit, David A. Brown, Vicky Wang Wei Tsai
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 227-228
Open Access | Times Cited: 12

Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes
Michael M. Richter, Mads N. Thomsen, Mads J. Skytte, et al.
Journal of the Endocrine Society (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4

Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids
Matteo Fiorenza, Antonio Checa, Rasmus M. Sandsdal, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101629-101629
Open Access | Times Cited: 4

Circulating Growth Differentiation Factor 15 (GDF15) in Paediatric Disease: A Systematic Review
David Kronenberger, Teresa A. Zimmers, Rick Ralston, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access

The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21
Suowen Xu, Zhenghong Liu, Tian Tian, et al.
Science Advances (2025) Vol. 11, Iss. 13
Open Access

Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress
Seyta Ley‐Ngardigal, Stéphane Claverol, Lauren Sobilo, et al.
Redox Biology (2025), pp. 103613-103613
Open Access

GDF15 links adipose tissue lipolysis with anxiety
Logan K. Townsend, Dongdong Wang, Carly M. Knuth, et al.
Nature Metabolism (2025)
Open Access

Cross-species comparison of pregnancy-induced GDF15
Anders B. Klein, Pablo Ranea‐Robles, Trine S. Nicolaisen, et al.
AJP Endocrinology and Metabolism (2023) Vol. 325, Iss. 4, pp. E303-E309
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top